BMO Capital Reiterates Outperform Rating on Biogen (BIIB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 219.35 +0.92 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.43 | 52 Week High | $333.65 | |||
| Open | $220.62 | 52 Week Low | $223.02 | |||
| Day High | $223.85 | P/E | 28.09 | |||
| Day Low | $219.23 | EPS | $7.81 | |||
| Volume | 188,184 | |||||
